American Shared Hospital Services (AMS) Financial Statements (2025 and earlier)

Company Profile

Business Address 601 MONTGOMERY STREET
SAN FRANCISCO, CA 94111
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,23612,79213,69014,53713,67613,083
Cash and cash equivalent14,23612,79213,69014,53713,67613,083
Restricted cash and investments250250118118118118
Receivables9,5976,9854,8474,6375,3264,773
Other undisclosed current assets1,5561,3381,8011,0799631,597
Total current assets:25,63921,36520,45620,37120,08319,571
Noncurrent Assets
Operating lease, right-of-use asset631365794146232
Property, plant and equipment(48,796)(52,237)(55,364)(54,423)(53,348)(52,110)
Intangible assets, net (including goodwill)1,3431,3431,3431,3431,3431,343
Goodwill1,2651,2651,2651,2651,2651,265
Intangible assets, net (excluding goodwill)787878787878
Other noncurrent assets1994824433533886
Other undisclosed noncurrent assets81,80979,13581,22779,62076,19574,425
Total noncurrent assets:35,18628,75927,70626,98724,37423,976
TOTAL ASSETS:60,82550,12448,16247,35844,45743,547
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,1652,5662,2983,0722,4452,258
Accounts payable859267315346297254
Accrued liabilities3,3062,2991,9832,7262,1482,004
Deferred revenue     554473
Debt3,0332,7102,0841,4591,2641,262
Asset retirement obligation271250250   
Other undisclosed current liabilities5,8675,2536,1475,5182,4931,261
Total current liabilities:13,33610,77910,77910,0496,7565,254
Noncurrent Liabilities
Long-term debt and lease obligation12,05012,89211,04110,45411,08011,493
Long-term debt, excluding current maturities12,05012,89211,04110,45411,08011,493
Liabilities, other than long-term debt3,0876863851880979
Deferred revenue    183553
Deferred income tax liabilities1,4726863822822890
Operating lease, liability1,615  112336
Total noncurrent liabilities:15,13712,96011,10411,30511,96012,472
Total liabilities:28,47323,73921,88321,35418,71617,726
Equity
Equity, attributable to parent26,54222,84122,62422,11121,89521,909
Common stock10,76310,76310,76310,76310,76310,763
Additional paid in capital8,4298,3308,2328,1348,0367,939
Retained earnings7,3503,7483,6293,2143,0963,207
Equity, attributable to noncontrolling interest5,8103,5443,6553,8933,8463,912
Total equity:32,35226,38526,27926,00425,74125,821
TOTAL LIABILITIES AND EQUITY:60,82550,12448,16247,35844,45743,547

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues7,0565,2165,6985,1345,5684,925
Cost of revenue(4,588)(3,073)(2,882)(3,032)(3,050)(3,017)
Cost of product and service sold(2,000)(1,810)(1,784)(1,746)(1,732)(1,843)
Other cost of operating revenue(2,418)(1,093)(1,028)(1,095)(1,023)(879)
Other undisclosed gross profit      
Gross profit:2,4682,1432,8162,1022,5181,908
Operating expenses(1,896)(1,879)(1,760)(1,735)(1,988)(1,539)
Other undisclosed operating loss(573)(349)(649)(277)(855)(271)
Operating income (loss):(1)(85)40790(325)98
Nonoperating income
(Investment Income, Nonoperating)
3,679     
Interest and debt expense   (287)(277)(277)(271)
Income (loss) from continuing operations before equity method investments, income taxes:3,678(85)120(187)(602)(173)
Other undisclosed income from continuing operations before income taxes59106395412390341
Income (loss) from continuing operations before income taxes:3,73721515225(212)168
Income tax expense (benefit)3144(338)(60)35(68)
Net income (loss):3,76865177165(177)100
Net income (loss) attributable to noncontrolling interest(166)54238(47)6688
Net income (loss) available to common stockholders, diluted:3,602119415118(111)188

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):3,76865177165(177)100
Comprehensive income (loss):3,76865177165(177)100
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(166)54238(47)6688
Comprehensive income (loss), net of tax, attributable to parent:3,602119415118(111)188

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: